Full-Time
Confirmed live in the last 24 hours
Biosimulation and data science solutions provider
No salary listed
Expert
Melbourne VIC, Australia
Certara provides biosimulation and data science solutions to enhance drug development and regulatory submissions. Their products include software and consulting services that help pharmaceutical and biotechnology companies, as well as regulatory agencies, make better decisions throughout the drug development process. Certara's software allows users to simulate biological processes and visualize data, which aids in improving the efficiency and success rates of clinical trials. Unlike many competitors, Certara combines advanced technologies like deep learning and artificial intelligence in their offerings. The company's goal is to optimize the drug development lifecycle, making it more effective and successful.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Princeton, New Jersey
Founded
2008
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Certara (NASDAQ: CERT) has appointed Dr. Adrian McKemey as President of Drug Development Solutions, effective March 3rd, 2025.
AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO.Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shield of California appoints Lois Quam as chief executive officer to lead Blue Shield of California, the first woman to serve as CEO in the health plan’s 86-year history. She joined the company as president in 2024. Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases appoints Troels Jordansen has joined Yaqrit as Chief Executive Officer.OP Solutions names Michael Kallish as Chief Executive Officer, effective immediately.Access TeleCare appoints Dr. Michael Genovese to Chief Medical Officer for Behavioral Health.Enveda appoints Jason Kim as Chief Financial Officer (CFO).Eko Health appoints of Justin Spencer as Chief Financial Officer (CFO). (Pull from site)Qure.ai appoints Jim Mercadante as its new Chief Commercial Officer. (Pull from site)Symplr, appoints Dr
In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics.
Certara appoints John Reynders as new independent board member.
RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5. Phoenix is the pharmaceutical industry's gold standard in pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. The Phoenix Platform is used by more than 75 of the top 100 pharmaceutical companies worldwide. Eleven regulatory agencies, including the U.S